Dr. Rezaizadeh (alternate sp. Rezai-zadeh) received his Ph.D. from the University of South Florida, where he evaluated the potential impact of a class of secondary plant metabolites (flavonoids) on Alzheimer’s disease. After receiving his doctorate, he joined the Regenerative Medicine Institute of Cedars-Sinai Medical Center, worked to establish a novel rat model of Alzheimer’s disease (TgF344-AD) and investigated potential immunotherapies for neurodegenerative disease. He continued his postdoctoral training at Pennington Biomedical Research Center, where he was awarded an F32 to analyze neural circuits that regulate metabolism with chemogenetic and optogenetic tools. Prior to joining NINDS, he received training in research administration from the University of Maryland, where he managed sponsored research programs for one of the University’s oldest public service organizations (Institute for Governmental Service and Research, est. 1947).